Cargando…
Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
Abnormality in myocardial copper homeostasis is believed to contribute to the development of cardiomyopathy. Trientine, a copper-chelating drug used in the management of patients with Wilson’s disease, demonstrates beneficial effects in patients with hypertrophic cardiomyopathy. This review aims to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505553/ https://www.ncbi.nlm.nih.gov/pubmed/36145368 http://dx.doi.org/10.3390/ph15091145 |